SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-136911
Filing Date
2021-04-28
Accepted
2021-04-28 16:16:02
Documents
9
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A d277536ddef14a.htm DEF 14A 920621
2 GRAPHIC g277536g10w54.jpg GRAPHIC 202157
3 GRAPHIC g277536g11e59.jpg GRAPHIC 159238
4 GRAPHIC g277536g17v71.jpg GRAPHIC 18671
5 GRAPHIC g277536g29h98.jpg GRAPHIC 22894
6 GRAPHIC g277536g29t38.jpg GRAPHIC 18671
7 GRAPHIC g277536g69a44.jpg GRAPHIC 92584
8 GRAPHIC g277536g71z96.jpg GRAPHIC 48831
9 GRAPHIC g277536g87y17.jpg GRAPHIC 51349
  Complete submission text file 0001193125-21-136911.txt   1769036
Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Filer) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35347 | Film No.: 21864428
SIC: 2834 Pharmaceutical Preparations